$179.25 +1.76 (%) Allergan Inc - NYSE

Oct. 20, 2014 | 04:00 PM

Partner Headlines

  1. Report: Actavis, Sanofi To Bid On Over-The-Counter Drug Maker

    Benzinga | Oct. 20, 2014 | 20:15PM EST
  2. Valeant To Up Allergan Bid?

    IBD | Oct. 20, 2014 | 19:10PM EST
  3. Can Valeant's Strong Q3 Entice Allergan?

    IBD | Oct. 20, 2014 | 18:47PM EST
  4. IBM's Report Weighs On The Dow, Apple Helps Boost The Nasdaq, S&P 500 Extends Winning Streak

    Benzinga | Oct. 20, 2014 | 16:57PM EST
  5. Shire Can Thrive Without AbbVie, Say Analysts

    IBD | Oct. 16, 2014 | 11:19AM EST
  6. Will Activis Win Competition For Allergan's Affection?

    Benzinga | Oct. 16, 2014 | 11:10AM EST
  7. AbbVie Board To Shareholders: Vote No On Shire Buy

    IBD | Oct. 16, 2014 | 00:52AM EST
  8. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue

    Benzinga | Oct. 13, 2014 | 05:22AM EST
  9. Patents, Taxes Lift Drug M&A

    IBD | Oct. 10, 2014 | 19:05PM EST
  10. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD | Oct. 10, 2014 | 17:37PM EST
  11. Allergan Hikes Profit Targets

    IBD | Oct. 9, 2014 | 18:45PM EST
  12. Dow Suffers Worst One Day Performance In 2014, Volatility Returns To The Markets

    Benzinga | Oct. 9, 2014 | 16:55PM EST
  13. Bears Regain Control As Stocks Suffer Sharp Losses

    IBD | Oct. 9, 2014 | 16:16PM EST
  14. Stocks' Slide Picks Up Steam; Icahn Note Buoys Apple

    IBD | Oct. 9, 2014 | 15:15PM EST
  15. Allergan Steeply Raises Guidance, Taunts Valeant

    IBD | Oct. 9, 2014 | 11:56AM EST
  16. Allergan, Inc. Shares Get A Bump Following Update On Performance Outlook

    Benzinga | Oct. 9, 2014 | 09:41AM EST
  17. Allergan, Inc Up As Deutsche Bank Initiates Coverage With Buy Rating

    Benzinga | Oct. 9, 2014 | 06:34AM EST
  18. Stock Futures Aim For A Bounce; Symantec Up On Split Reports

    IBD | Oct. 8, 2014 | 09:01AM EST
  19. #PreMarket Primer: Wednesday, October 8: IMF Cuts Global Growth Prospects, Puts A Damper On Wall Street

    Benzinga | Oct. 8, 2014 | 08:19AM EST
  20. CNBC's Stock Pops & Drops From October 7

    Benzinga | Oct. 8, 2014 | 07:40AM EST
  21. Benzinga's M&A Chatter for Tuesday October 7, 2014

    Benzinga | Oct. 7, 2014 | 20:16PM EST
  22. Salix, Actavis Among Big Cap Pharmas In Merger Mambo

    IBD | Oct. 7, 2014 | 19:33PM EST
  23. Allergan deal buzz intensifies

    IBD | Oct. 7, 2014 | 18:49PM EST
  24. Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

    IBD | Oct. 7, 2014 | 18:33PM EST
  25. Ackman's Pershing Square Could Raise Allergan Takeover Bid, WSJ Reports

    Benzinga | Oct. 7, 2014 | 18:08PM EST
  26. Allergan, Inc. Spikes On Renewed Interest From Actavis PLC

    Benzinga | Oct. 7, 2014 | 15:50PM EST
  27. GoPro Among Top 6 Stocks Outperforming The Market

    IBD | Oct. 7, 2014 | 08:02AM EST
  28. Gilead Among Top IBD 50 Stocks Heading Into Earnings

    IBD | Oct. 4, 2014 | 08:02AM EST
  29. Medical Stocks End Week On High Note, Biotechs Lead

    IBD | Oct. 4, 2014 | 08:02AM EST
  30. Jazz Pharmaceuticals Uses New Cash To Buy For Growth

    IBD | Oct. 3, 2014 | 14:39PM EST
  31. Salix Cancels Tax Inversion, Opens Way For Buyers

    IBD | Oct. 3, 2014 | 11:11AM EST
  32. What Sectors Sizzle As M&A Deals Notch New Boom Year?

    IBD | Oct. 2, 2014 | 18:53PM EST
  33. Top Fund Buys: Chipotle, Allergan, Jazz, Gilead

    IBD | Oct. 2, 2014 | 18:25PM EST
  34. Deal Frenzy: 2014 Sees Record M&A Volume

    FoxBusiness | Sep. 30, 2014 | 00:00AM EST
  35. Tax Inversions Help Push Global M&A To 7-Year High

    IBD | Sep. 29, 2014 | 18:33PM EST
  36. Large-Cap Tech, Biotech Names Hang Tough In Shaky Market

    IBD | Sep. 29, 2014 | 18:32PM EST
  37. Rebound Efforts Fade For Stocks; Synchronoss Clears Resistance

    IBD | Sep. 29, 2014 | 13:32PM EST
  38. UPDATE: Allergan Board Offers Statement, Says Valeant's Bid 'Grossly Inadequate'

    Benzinga | Sep. 29, 2014 | 08:05AM EST
  39. Jackson Square Partners Joins Investors Opposing Allergan Bid for Salix

    Benzinga | Sep. 28, 2014 | 11:05AM EST
  40. Facebook Among 5 IBD 50 Stocks Holding Near Highs

    IBD | Sep. 27, 2014 | 08:02AM EST
  41. Meet 5 Top Stocks With Rising Earnings Estimates

    IBD | Sep. 26, 2014 | 08:02AM EST
  42. A Few Reasons Why AbbVie's Momentum Will Continue

    GuruFocus | Sep. 25, 2014 | 17:53PM EST
  43. Valeant: Glaucoma Drug Is Potential Blockbuster

    IBD | Sep. 25, 2014 | 13:47PM EST
  44. Benzinga's M&A Chatter for Wednesday September 24, 2014

    Benzinga | Sep. 24, 2014 | 21:09PM EST
  45. Pharma Buyout Bids Beat On

    IBD | Sep. 24, 2014 | 18:55PM EST
  46. Valeant Ends Prince Charming Act; Allergan Hopes Rise

    IBD | Sep. 24, 2014 | 15:55PM EST
  47. #PreMarket Primer: Wednesday, September 24: US Economy Looking Strong In The Third Quarter

    Benzinga | Sep. 24, 2014 | 07:13AM EST
  48. Ackman forewarns Allergan

    IBD | Sep. 23, 2014 | 18:45PM EST
  49. Benzinga's M&A Chatter for Tuesday September 23, 2014

    Benzinga | Sep. 23, 2014 | 18:35PM EST
  50. Stocks Finish Lower Among Takeover Rumors

    IBD | Sep. 23, 2014 | 18:06PM EST
Trading Center